Nucleon Therapeutics Llp - Company Profile

It is a travel and hospitality limited liability partnership based in Mumbai, Maharashtra, India, established in 2017.
2017 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Nucleon Therapeutics Llp

Nucleon Therapeutics Llp, a active limited liability partnership, was established on 24 April 2017 in Mumbai, Maharashtra, India. Engaging in consumer professional services within the travel and hospitality sector, it holds LLPIN: AAJ-2427. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Rashmi Santosh Mahadik (Designated Partner), Anushka Vilas Salvi (Designated Partner). Past directors included Ujwala Vilas Salvi, Vilas Maruti Salvi. Its latest date of accounts and solvency statement 31 March 2023. It is based at Office 204/205, So Lucky Corner Coop Soc, Opp. Holy Family Church, Andheri East, Mumbai, Maharashtra, 400099.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAJ-2427

  • Incorporation Date

    24 April 2017

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 8 Year, 9 Months
  • Last Filing with ROC 31 Mar 2023
Company report

Nucleon Therapeutics Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nucleon Therapeutics Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Nucleon Therapeutics Llp?
Current Designated Partners
Name Designation Appointment Date Status
Rashmi Santosh Mahadik Designated Partner 30 Mar 2019 Current
Anushka Vilas Salvi Designated Partner 20 Aug 2019 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 20 Aug 2019 Past
Pramod Abcsdd Designated Partner 30 Mar 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nucleon Therapeutics Llp.

Enhance accessibility to Nucleon Therapeutics Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Nucleon Therapeutics Llp revenue growth over time
Nucleon Therapeutics Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nucleon Therapeutics Llp?

Unlock access to Nucleon Therapeutics Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nucleon Therapeutics Llp?

Unlock and access historical data on people associated with Nucleon Therapeutics Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nucleon Therapeutics Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucleon Therapeutics Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nucleon Therapeutics Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Nucleon Therapeutics Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Progress on Nucleon Therapeutics Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Anushka Vilas Salvi was appointed as a Designated Partner was appointed as a Designated Partner on 20 Aug 2019 & has been associated with this company since 6 years 5 months . was completed.

  • Director Appointment

    Rashmi Santosh Mahadik was appointed as a Designated Partner was appointed as a Designated Partner on 30 Mar 2019 & has been associated with this company since 6 years 10 months . was recorded as a recent event.

  • LLP Incorporation

    The activity Nucleon Therapeutics Llp was registered on 24 Apr 2017 with Roc Mumbai & aged 8 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Nucleon Therapeutics Llp?

The LLPIN of Nucleon Therapeutics Llp is AAJ-2427.

Where is Nucleon Therapeutics Llp headquartered?

Nucleon Therapeutics Llp is headquartered at Office 204/205, So Lucky Corner Coop Soc, Opp. Holy Family Church, Andheri East, Mumbai, Maharashtra, 400099.

When was Nucleon Therapeutics Llp incorporated?

Nucleon Therapeutics Llp was incorporated on 24 April 2017.

Who are the current directors of Nucleon Therapeutics Llp?

The current directors of Nucleon Therapeutics Llp are

What is the primary industry of Nucleon Therapeutics Llp?

The primary industry of Nucleon Therapeutics Llp is Travel And Hospitality.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available